NYSE$BLCO
Bausch + Lomb Corp · Q1 2026 earnings
Q1 2026 earnings · · Before market open · Investor relations
Briefing
Bausch + Lomb reported Q1 2026 revenues of $1.24B and a net loss attributable to Bausch + Lomb of $71M, with diluted loss per share of $0.20.
Revenues rose 9% to $1.24 billion while the company remained GAAP unprofitable. Operating income was $33 million versus an operating loss a year ago. Net loss attributable to Bausch + Lomb was $71 million, or $0.20 per share ($0.60 loss prior year), as interest and restructuring costs persisted.
- Revenues $1.24B (+9% YoY).
- Operating income $33M vs. $(83)M prior year.
- Net loss to B+L $71M; diluted EPS $(0.20).
- Top-10 products/franchises 57% of revenue.
Headline financials
Revenue & EPS history
Bausch + Lomb · Revenue · Quarterly
$1.24B
Revenue by segment
Bausch + Lomb · $1.01B total across 3 segments · Q3 2023
- Vision Care$648M+8.4%64.3%
- Surgical$185M+7.6%18.4%
- Pharmaceuticals$174M+1.2%17.3%
Forward guidance
Outlook focuses on organic revenue growth targets and separation from BHC; no GAAP EPS guide in the filing.
Tailwinds
- Return to positive operating income.
- Revenue growth across vision care franchises.
- Separation planning progresses.
Headwinds
- Still GAAP unprofitable at net line.
- Interest and separation costs elevated.
- FX and integration complexity.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2026
-1.0%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-1.0%
Avg return
30 days after
43%
9 / 21 earnings
Positive
+18.7%
Q4 2023
Best reaction
-15.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.8% | +2.9% | -1.0% | |
| Q4 2025 | +0.2% | +1.5% | -11.3% | |
| Q3 2025 | +2.1% | +0.3% | +6.5% | |
| Q1 2025 | -15.7% | -17.1% | -16.4% | |
| Q4 2024 | -0.3% | -3.3% | -4.8% | |
| Q3 2024 | -2.3% | -4.3% | -4.5% | |
| Q2 2024 | -0.1% | -8.7% | -2.6% | |
| Q1 2024 | -4.7% | -0.7% | +5.5% | |
| Q4 2023 | +18.7% | +15.7% | +10.8% | |
| Q3 2023 | +4.6% | +2.9% | -4.3% | |
| Q2 2023 | -2.5% | -3.4% | -7.2% | |
| Q1 2023 | +0.1% | +4.6% | +4.4% | |
| Q4 2020 | +0.4% | -3.7% | -14.1% | |
| Q4 2022 | +0.4% | -3.7% | -14.1% | |
| Q3 2022 | -4.9% | +5.6% | +7.9% | |
| Q3 2021 | -4.9% | +5.6% | +7.9% | |
| Q2 2022 | +4.7% | +6.3% | +1.2% | |
| Q2 2021 | +4.7% | +6.3% | +1.2% | |
| Q1 2022 | -6.8% | -14.6% | +5.0% | |
| Q4 2021 | -6.8% | -14.6% | +5.0% | |
| Q1 2021 | -6.8% | -14.6% | +5.0% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro